Spots Global Cancer Trial Database for atypical endometrial hyperplasia
Every month we try and update this database with for atypical endometrial hyperplasia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate | NCT00483327 | Atypical Endome... Endometrial Car... | Megestrol Aceta... | 18 Years - | NYU Langone Health | |
| Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women | NCT00490087 | Atypical Endome... Atypical Endome... | Levonorgestrel ... | 25 Years - 50 Years | IRCCS Burlo Garofolo | |
| Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC | NCT03463252 | Endometrial Can... Atypical Endome... | Progesterone Mirena® GnRH agonist | - 40 Years | West China Second University Hospital | |
| Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women | NCT00490087 | Atypical Endome... Atypical Endome... | Levonorgestrel ... | 25 Years - 50 Years | IRCCS Burlo Garofolo | |
| Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer | NCT05647109 | Endometrial Car... Atypical Endome... | No intervention | 17 Years - 45 Years | Peking University People's Hospital | |
| Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer | NCT01943058 | Atypical Endome... Endometrial Ade... Recurrent Endom... Stage IA Endome... Stage IB Endome... Stage II Endome... Stage IIIA Endo... Stage IIIB Endo... Stage IIIC Endo... Stage IVA Endom... Stage IVB Endom... | megestrol aceta... levonorgestrel-... laboratory biom... questionnaire a... | 18 Years - 44 Years | University of Southern California | |
| GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients | NCT05316935 | Endometrial Neo... Atypical Endome... Progesterone Re... | GnRHa Letrozole 2.5mg Diane-35 MET | 18 Years - 45 Years | Fudan University | |
| Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy | NCT03671811 | Atypical Endome... Endometrial Car... | Megestrol Aceta... Pterostilbene | 18 Years - | City of Hope Medical Center | |
| Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer | NCT05051722 | Endometrial Can... Cervical Cancer Atypical Endome... Cervical Dyspla... Adnexal Mass Ovarian Cancer | Tampon Collecti... Blood Collectio... | 18 Years - | Mayo Clinic | |
| Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer | NCT01943058 | Atypical Endome... Endometrial Ade... Recurrent Endom... Stage IA Endome... Stage IB Endome... Stage II Endome... Stage IIIA Endo... Stage IIIB Endo... Stage IIIC Endo... Stage IVA Endom... Stage IVB Endom... | megestrol aceta... levonorgestrel-... laboratory biom... questionnaire a... | 18 Years - 44 Years | University of Southern California | |
| Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer | NCT02397083 | Atypical Endome... FIGO Grade 1 En... FIGO Grade 2 En... | Everolimus Laboratory Biom... Levonorgestrel-... | 18 Years - | M.D. Anderson Cancer Center | |
| CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells | NCT00892866 | Atypical Endome... Human Papilloma... Stage 0 Cervica... | Cytology Specim... Laboratory Biom... | 18 Years - | GOG Foundation | |
| GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients | NCT05316935 | Endometrial Neo... Atypical Endome... Progesterone Re... | GnRHa Letrozole 2.5mg Diane-35 MET | 18 Years - 45 Years | Fudan University | |
| Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer | NCT05051722 | Endometrial Can... Cervical Cancer Atypical Endome... Cervical Dyspla... Adnexal Mass Ovarian Cancer | Tampon Collecti... Blood Collectio... | 18 Years - | Mayo Clinic | |
| Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women | NCT00490087 | Atypical Endome... Atypical Endome... | Levonorgestrel ... | 25 Years - 50 Years | IRCCS Burlo Garofolo | |
| GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients | NCT06379113 | Endometrial Neo... Atypical Endome... Progesterone Re... Obesity | GnRH antagonist Letrozole 2.5mg | 18 Years - 45 Years | Fudan University | |
| CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells | NCT00892866 | Atypical Endome... Human Papilloma... Stage 0 Cervica... | Cytology Specim... Laboratory Biom... | 18 Years - | GOG Foundation | |
| Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer | NCT00788671 | Atypical Endome... Stage I Uterine... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... | Laboratory Biom... Levonorgestrel-... Quality-of-Life... | 18 Years - | M.D. Anderson Cancer Center | |
| Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer | NCT02397083 | Atypical Endome... FIGO Grade 1 En... FIGO Grade 2 En... | Everolimus Laboratory Biom... Levonorgestrel-... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
